Company to buy
- Size: Small to medium business
- Sales: 5 million EUR
- Location: Southern Europe
- Reason for acquisition: The management wants to expand and diversify their business
- #CFIE PHB163
Overview of this buyer for nutricial CMOs in Southern Europe
The buyer is an innovation-driven biotechnology company doing research and development, manufacturing, sales, distribution, and marketing of pharmaceuticals, vaccines, and biosimilars. The buyer company was established in the 1980s with a commitment to make innovative products affordable and accessible to a wide consumer market.
The buyer is expanding its business, including everything from innovative products to customers in the market, from manufacturing to regulatory approvals, thereby laying the foundation for a translation of its vision of becoming a key market leader in biotechnology.
Profile (strategy) of this buyer for nutricial CMOs in Southern Europe
The buyer employs innovative research techniques and tools to provide improved or new biologicals for the prevention or treatment of infectious diseases and lifestyle-related disorders. Its special focus is on identifying leads for the development of products that prevent or control emerging/pandemic infections.
The buyer’s multidisciplinary R&D teams employ hardcore molecular biology strategies, cell culture, and genetic engineering technologies to offer first-class products through the use of mammalian cell expression systems, bacterial expression systems, or viral vector expression systems to meet unmet medical needs.
Innovative research and development are integrated with high-quality manufacturing capability and sales and marketing expertise for taking ideas from the drawing board to the market in a proactive manner.
The buyer is familiar with pain management, diabetes, cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products, and vaccines, as well as transplant, nephrology, and diabetes with some exclusive products based on patented drug delivery systems.
Contact us to get details about this buyer for nutricial CMO in Southern Europe
Activities and products of a suitable target
The buyer is interested in companies with strong expertise in nutricial CMOs, in order to enter a new product segment. In the medical and biotechnological segment, the company has operations in pain management, diabetes, and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products, and vaccines.
Highlights of this buyer for nutricial CMOs in Southern Europe
- The company has more than 30 years of history
- Strong R&D
- The company is a market leader
More information on this buyer for nutricial CMOs in Southern Europe
Please get in touch if you are interested in learning more about this buyer for nutricial CMOs in Southern Europe. For more cmo companies for sale please visit the section cmo companies for sale. For other cmo buyers, please visit the section cmo companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.